SEC Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending June 30, 2018. The document discloses equity securities held by the company that are subject to reporting requirements under the Securities Exchange Act of 1934. It does not contain Alphabet's own financial performance data (revenue, profit, etc.) but rather details its investment portfolio.
Key Financial Metrics and Portfolio Holdings
The filing lists specific equity positions held by Alphabet Inc. as of the reporting date. The table below summarizes the disclosed holdings, including the issuer, title of class, CUSIP, share count, and value (in thousands).
| Issuer | Title of Class | Shares (x$1000) | Value ($) | Voting Authority |
|---|---|---|---|---|
| Arcus Biosciences Inc | COM | 61,809 | 5,049,786 | Sole |
| Arris Intl Inc | SHS | 237,202 | 9,703,500 | Sole |
| Arsanis Inc | COM | 9,831 | 451,362 | Sole |
| Autolus Therapeutics PLC | SPON ADS | 19,130 | 714,072 | Sole |
| Cloudera Inc | COM | 11,668 | 855,420 | Sole |
| Denali Therapeutics Inc | COM | 8,180 | 536,411 | Sole |
| DocuSign Inc | COM | 77,366 | 1,461,106 | Sole |
| Dropbox Inc | CL A | 423 | 13,033 | Sole |
| Evelo Biosciences Inc | COM | 12,514 | 1,060,495 | Sole |
| Forty Seven Inc | COM | 24,735 | 1,545,966 | Sole |
| JD.com Inc | SPON ADR CL A | 527,908 | 13,553,474 | Sole |
| Magenta Therapeutics Inc | COM | 45,078 | 3,339,138 | Sole |
| Pluralsight Inc | CL A | 2,480 | 101,442 | Sole |
| Snap Inc | CL A | 34,277 | 2,618,548 | Sole |
| Spero Therapeutics Inc | COM | 16,320 | 1,112,473 | Sole |
| Square Inc | CL A | 1,812 | 29,400 | Sole |
| Zscaler Inc | COM | 99,691 | 2,788,560 | Sole |
Note: The filing text does not provide a clear aggregate total value for the entire portfolio, nor does it disclose Alphabet's own revenue, profit, cash flow, or debt levels. The "Value" column represents the value of the specific holdings listed.
Material Changes and Guidance
The filing text does not provide a clear value for material changes versus the prior comparable period, as Form 13F tables typically list current holdings without explicit comparative analysis in the text body. There is no management commentary, guidance, outlook, or discussion of risks and contingencies regarding Alphabet's operations within this specific document.
Key Facts for Investor Verification
- Portfolio Composition: Alphabet holds significant positions in biotechnology (e.g., Arcus, Denali, Magenta) and technology sectors (e.g., JD.com, Snap, Zscaler).
- Largest Disclosed Position: JD.com Inc represents the largest single value in this specific table at approximately $13.55 million.
- Voting Rights: Alphabet exercises sole voting authority for all listed securities; no shared or none voting authority is reported for these items.
- Scope Limitation: This document is a partial snapshot of holdings and does not reflect Alphabet's total assets, liabilities, or operational financial performance.